시장보고서

상품코드

1629270

POC 감염증 검사 시장 : 기술별, 질환별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2024-2032년)

Point of Care Infectious Disease Testing Market, By Technology, By Disease, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

POC(Point of Care) 감염증 검사 시장 규모는 2023년에 114억 943만 달러에 달하며, 2024-2032년에 CAGR 4.69%로 확대

POC 감염 검사 시장 역학

감염병 발병률 증가는 시장 성장을 가속할 것으로 예상됩니다.

독감, COVID-19, HIV, 간염, STI 등 감염성 질환의 유행이 증가함에 따라 신속하고 접근하기 쉬운 검사 솔루션에 대한 수요가 증가하고 있으며, POC 테스트는 즉각적인 치료 결정을 용이하게 하는 적시 결과를 제공합니다. for Biotechnology Information에 따르면 감염성 질환은 여전히 전 세계에서 연간 5,200만 명(33%) 이상이 사망하는 주요 원인 중 하나입니다. 또한 신속 검사에 대한 수요 증가는 시장에 성장 기회를 제공할 수 있습니다. 그러나 일부 POC 검사의 정확성과 신뢰성에 대한 우려는 시장 성장을 저해할 수 있습니다.

POC 감염병 검사 시장 : 주요 고려사항

당사의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 약 4.69%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

기술별로는 분자진단이 2023년에 가장 높은 시장 점유율을 보였습니다.

질병별로는 COVID-19가 2023년 주요 유형으로 나타났습니다.

최종사용자별로는 클리닉이 2023년 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 주요 수입원이었습니다.

POC 감염병 검사 시장 : 세분화 분석

POC 감염 테스트 세계 시장은 기술, 질병, 최종사용자, 지역을 기준으로 세분화됩니다.

시장은 기술별로 측면 흐름 면역측정법, 응집 시험법, 플로우 스루 시험법/면역 응집 측정법, 분자진단법, 기타 세 가지 부문으로 나뉩니다. 이 중 분자진단학은 시장에서 선도적인 위치를 차지하고 있습니다. 이 분야에서는 중합효소연쇄반응(PCR), 차세대염기서열분석(NGS) 등의 첨단 분자학적 기법을 이용하여 환자의 진료 시점 또는 그 근처에서 시행되는 감염성 질환의 신속하고 정확한 검사가 중요시되고 있습니다.

시장은 질병별로 HIV POC, 클로스트리디움 디피실 POC, HBV POC, 폐렴 또는 연쇄상구균 관련 감염, 호흡기세포융합바이러스(RSV) POC, HPV POC, 인플루엔자/독감 POC, HCV POC, MRSA POC, 결핵 및 약제 내성 결핵 POC, HSV POC, COVID-19 POC, 기타 등이며, COVID-19 부문이 시장에서 지배적인 위치를 차지하고 있습니다. 이번 팬데믹은 바이러스 확산을 완화하고 환자 관리를 강화하기 위해 신속하고 정확한 검사의 긴급한 필요성을 강조했습니다.

시장은 사용자에 따라 진료소, 병원, 재택 자가 검사, 노인 요양원, 연구소 등 두 가지 부문으로 나뉩니다. 클리닉은 시장에서 지배적인 위치를 차지하고 있습니다. 1차 진료, 응급 치료, 전문 클리닉을 포함한 이들 시설은 현장에서 검사를 실시할 수 있다는 점에서 큰 이점을 누리고 있으며, 환자 관리와 관련된 신속한 의사결정을 촉진하고 있습니다.

POC 감염병 검사 시장 : 지역별 분석

이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카를 포함한 광범위한 지역에 걸쳐 있습니다. 이 지역은 사업 활동에 기여하는 국가를 기준으로 더 세분화됩니다. 북미는 시장 성장을 주도하는 지역이지만, 이는 주로 다양한 감염병을 식별하기 위한 고급 현장진단(POC) 진단의 채택이 증가하고 있기 때문입니다. 이 지역은 혁신적인 진단 기술의 통합을 촉진하는 탄탄한 의료 인프라의 혜택을 누리고 있습니다. 병원, 진료소, 검사실은 환자 치료를 개선하기 위해 POC 검사 솔루션을 도입하고 있습니다. 국립생물공학정보센터에 따르면 2020년 7월 13일 현재 미국에서는 330만 명 이상의 주민이 코로나바이러스감염증-19(COVID-19) 진단을 받았으며, 13만 5,000명 이상의 사망자가 보고되었습니다. 유럽은 재택의료 서비스 수요 증가에 힘입어 시장 성장률 2위 지역으로 꼽히고 있습니다.

POC 감염병 검사 시장 : 경쟁 구도

신속하고 정확한 진단 솔루션에 대한 수요 증가에 힘입어 현장진단(POC) 감염병 검사 시장은 다양한 이해관계자들이 치열한 경쟁을 벌이고 있는 것이 특징입니다. 다양한 기업이 의료 기관 및 기술 기업과 전략적 제휴를 맺어 검사 능력을 향상시키고 시장에서의 입지를 확대하기 위해 노력하고 있습니다. 이 경쟁 환경은 역동적이고 진화하고 있습니다. 신속하고 정확한 진단의 필요성이 증가함에 따라 기업은 변화하는 시장 수요와 기술 혁신에 민첩하게 대응해야 합니다.

개요
- 부문별 점유율 분석 : 질환별
- HIV POC
- 클로스트리듐 디피실 POC
- HBV POC
- 폐렴·연쇄구균 관련 감염증
- 호흡기세포융합바이러스(RSV) POC
- HPV POC
- 인플루엔자/인플루엔자 POC
- HCV POC
- MRSA POC
- 결핵과 약제 내성 결핵 POC
- HSV POC
- COVID-19
- 기타

제9장 POC 감염증 검사 시장 : 최종사용자별

개요
- 부문별 점유율 분석 : 최종사용자별
- 진료소
- 병원
- 재택 자가 검사
- Assisted Living Healthcare Facilities
- 연구실

제10장 POC 감염증 검사 시장 : 지역별

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : POC 감염증 검사 업계

경쟁 대시보드
기업 개요
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Becton, Dickinson &Company
- Abbott
- Thermo Fisher Scientific Inc
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics.
- Others

제12장 AnalystView의 전방위적 분석

KSA 25.02.18

REPORT HIGHLIGHT

Point of Care Infectious Disease Testing Market size was valued at USD 11,409.43 million in 2023, expanding at a CAGR of 4.69% from 2024 to 2032.

Point of Care Infectious Disease Testing (POC IDT) refers to diagnostic tests conducted at or near the site of patient care, allowing for the rapid detection of infectious diseases. This approach enables healthcare providers to obtain immediate results, facilitating timely diagnosis and treatment decisions without the need to send samples to a central laboratory. POC IDT represents a significant progression in healthcare, offering rapid and accessible diagnostic solutions that enhance patient care and contribute positively to public health outcomes.

Point of Care Infectious Disease Testing Market- Market Dynamics

Rising Incidence of Infectious Diseases is expected to drive the growth of the market.

As the prevalence of infectious diseases such as influenza, COVID-19, HIV, hepatitis, and STIs rises, the demand for rapid and accessible testing solutions increases. POC tests provide timely results that facilitate immediate treatment decisions. According to the National Center for Biotechnology Information, Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Furthermore, Growing Demand for Rapid Testing may create growth opportunities for the market. However, Concerns about the accuracy and reliability of some POC tests can hinder market growth.

Point of Care Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.69% over the forecast period (2024-2032)

Based on Technology segmentation, Molecular Diagnostics was predicted to show maximum market share in the year 2023

Based on Disease segmentation, COVID-19 was the leading type in 2023

Based on End-User segmentation, Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Point of Care Infectious Disease Testing Market- Segmentation Analysis:

The Global Point of Care Infectious Disease Testing Market is segmented based on Technology, Disease, End-User, and Region.

The market is classified into three segments according to technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test/Immunoconcentration Assay, Molecular Diagnostics, and Others. Among these, Molecular Diagnostics holds a leading position in the market. This segment emphasizes the importance of swift and precise testing for infectious diseases conducted at or near the point of patient care, employing sophisticated molecular methods such as polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The market is classified into two primary categories based on diseases: HIV POC, Clostridium Difficile POC, HBV POC, pneumonia or Streptococcus-associated infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, COVID-19, and others. The COVID-19 segment holds a dominant position in the market. The pandemic underscored the urgent necessity for swift and precise testing to mitigate the virus's spread and enhance patient management.

The market is categorized into two segments according to the Users: Clinics, Hospitals, Home and Self Testing, Assisted Living Healthcare Facilities, and Laboratories. Clinics hold a dominant position within the market. These facilities, which encompass primary care, urgent care, and specialty clinics, gain significant advantages from the capability to conduct tests on-site, facilitating prompt decision-making regarding patient management.

Point of Care Infectious Disease Testing Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America is the leading region in market growth, primarily due to the rising adoption of advanced point-of-care diagnostics for identifying various infectious diseases. The region benefits from a robust healthcare infrastructure that facilitates the integration of innovative diagnostic technologies. Hospitals, clinics, and laboratories are progressively implementing point-of-care testing solutions to improve patient care. According to the National Center for Biotechnology Information, as of July 13, 2020, over 3.3 million residents in the United States have been diagnosed with coronavirus disease 2019 (COVID-19), with more than 135,000 fatalities reported. Europe ranks as the second-largest region for market growth, driven by an increasing demand for home healthcare services.

Point of Care Infectious Disease Testing Market- Competitive Landscape:

The market for point-of-care (POC) Infectious Disease Testing is marked by significant competition among numerous stakeholders, fueled by the increasing need for swift and precise diagnostic solutions. A variety of companies are engaging in strategic alliances with healthcare organizations and technology enterprises to improve their testing capabilities and broaden their market presence. This competitive environment is dynamic and evolving. As the necessity for rapid and accurate diagnostics escalates, companies must remain agile in responding to shifting market demands and technological innovations.

Recent Developments:

On July 29, 2024, Roche announced the successful completion of its acquisition of LumiraDx's Point of Care technology, having obtained all necessary antitrust and regulatory approvals. Roche will now proceed with the comprehensive integration of the innovative multi-assay point-of-care platform, along with the associated research and development, operational, and commercial facilities, into its global organization.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann-La Roche Ltd
Siemens Healthineers
Becton, Dickinson & Company
Abbott
Thermo Fisher Scientific Inc
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Incorporated
Bio-Rad Laboratories Inc.
bioMerieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics.
Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Lateral Flow Immunoassay
Agglutination Test
Flow-through test/Immunoconcentration Assay
Molecular Diagnostics
Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

HIV POC
Clostridium Difficile POC
HBV POC
Pneumonia Or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB & Drug-resistant TB POC
HSV POC
COVID-19
Other

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Clinics
Hospitals
Home and Self Testing
Assisted Living Healthcare Facilities
Laboratory

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Point of Care Infectious Disease Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Point of Care Infectious Disease Testing Market Snippet by Technology
- 2.1.2. Point of Care Infectious Disease Testing Market Snippet by Disease
- 2.1.3. Point of Care Infectious Disease Testing Market Snippet by End-User
- 2.1.4. Point of Care Infectious Disease Testing Market Snippet by Country
- 2.1.5. Point of Care Infectious Disease Testing Market Snippet by Region
2.2. Competitive Insights

3. Point of Care Infectious Disease Testing Key Market Trends

3.1. Point of Care Infectious Disease Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Point of Care Infectious Disease Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Point of Care Infectious Disease Testing Market Opportunities
3.4. Point of Care Infectious Disease Testing Market Future Trends

4. Point of Care Infectious Disease Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Point of Care Infectious Disease Testing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Point of Care Infectious Disease Testing Market Landscape

6.1. Point of Care Infectious Disease Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Point of Care Infectious Disease Testing Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 7.1.2. Lateral Flow Immunoassay
- 7.1.3. Agglutination Test
- 7.1.4. Flow-through test/Immunoconcentration Assay
- 7.1.5. Molecular Diagnostics
- 7.1.6. Others

8. Point of Care Infectious Disease Testing Market - By Disease

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
- 8.1.2. HIV POC
- 8.1.3. Clostridium Difficile POC
- 8.1.4. HBV POC
- 8.1.5. Pneumonia Or Streptococcus Associated Infections
- 8.1.6. Respiratory Syncytial Virus (RSV) POC
- 8.1.7. HPV POC
- 8.1.8. Influenza/Flu POC
- 8.1.9. HCV POC
- 8.1.10. MRSA POC
- 8.1.11. TB & Drug-resistant TB POC
- 8.1.12. HSV POC
- 8.1.13. COVID-19
- 8.1.14. Other

9. Point of Care Infectious Disease Testing Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Clinics
- 9.1.3. Hospitals
- 9.1.4. Home and Self Testing
- 9.1.5. Assisted Living Healthcare Facilities
- 9.1.6. Laboratory

10. Point of Care Infectious Disease Testing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Point of Care Infectious Disease Testing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Point of Care Infectious Disease Testing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Point of Care Infectious Disease Testing Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Point of Care Infectious Disease Testing Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Point of Care Infectious Disease Testing Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point of Care Infectious Disease Testing Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd
- 11.2.2. Siemens Healthineers
- 11.2.3. Becton, Dickinson & Company
- 11.2.4. Abbott
- 11.2.5. Thermo Fisher Scientific Inc
- 11.2.6. Chembio Diagnostics Inc.
- 11.2.7. Trinity Biotech
- 11.2.8. Cardinal Health
- 11.2.9. Quest Diagnostics Incorporated
- 11.2.10. Bio-Rad Laboratories Inc.
- 11.2.11. bioMerieux SA
- 11.2.12. Sight Diagnostics Ltd.
- 11.2.13. Gene POC
- 11.2.14. Trivitron Healthcare
- 11.2.15. OJ-Bio Ltd.
- 11.2.16. Ortho-Clinical Diagnostics.
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us